MedPath

To study one of the reversible causes of brain damage at IGIMS, Patna.

Not Applicable
Conditions
Health Condition 1: G909- Disorder of the autonomic nervoussystem, unspecified
Registration Number
CTRI/2022/03/040763
Lead Sponsor
IGIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Presence of headache, seizures, encephalopathy or visual disturbances and typical radiological changes of vasogenic edema.

Exclusion Criteria

Prior history of seizures, treatment at another hospital for more than 24 hours, other significant CNS lesions and inadequate data available.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study about the variable presentation and determinants of recovery from posterior reversible encephalopathy syndrome (PRES).Timepoint: At baseline, at 4 weeks then at every 4 weeks interval till study continued.
Secondary Outcome Measures
NameTimeMethod
To initiate the treatment for the speedy recovery from PRES and to reduce the hospital stay.Timepoint: At the end of study
© Copyright 2025. All Rights Reserved by MedPath